90911-9
Eicosapentaenoate (C20:5w3)+Docosapentaenate (C22:5w3)+Docosahexaenoate (C22:6w3)/Fatty acids.C14-C22 in Blood
Active
Part Descriptions
LP269615-3 Eicosapentaenoate+Docosapentaenate w3+Docosahexaenoate
Docosapentaenoic acid designates any straight chain 22:5 fatty acid. Two isomers are of particular interest
all-cis-7,10,13,16,19-docosapentaenoic acid is an ω-3 fatty acid with the trivial name clupanodonic acid, commonly called DPA. It is an intermediary between eicosapentaenoic acid (EPA, 20:5 ω-3) and docosahexaenoic acid (DHA, 22:6 ω-3). Seal oil is a rich source.
all-cis-4,7,10,13,16-docosapentaenoic acid is an ω-6 fatty acid with the trivial name Osbond acid. It is formed by an elongation and desaturation of arachidonic acid 20:4 ω-6. In mammals, clupanodonic acid deficiency is accompanied by an increase of this isomer; the Osbond/DHA ratio is thus a marker of dietary DHA sufficiency
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
LP269615-3 Eicosapentaenoate+Docosapentaenate w3+Docosahexaenoate
Eicosapentaenoate (EPA) is a long chain omega-3 fatty acid that is present throughout the body including in cell membranes. EPA is found in fatty fish including salmon, tuna, mackerel, sardines, shellfish, and herring. EPA can be biosynthesized from alpha-linolenic acid (ALA), but it is much more efficient to increase levels by including EPA-rich sources in one's diet. EPA has anti-inflammatory properties that are vital to fetal development and the process of healthy aging. Its anti-inflammatory effects are due to reduced gene expression of genes involved in inflammatory and atherogenesis-related pathways, thereby lowering the risk of cardiovascular disease. EPA has also been found to increase platelet stability, decrease endothelial activation, and improve vascular permeability. Taking EPA supplements leads to an increased amount of EPA in the plaque of carotid arteries which may decrease inflammation and increase plaque stability. PMID: 22332096 Many other studies have been run that show acorrelation between higher plasma levels of EPA and reduced symptoms of disease, some of which include Alzheimer's disease, depression, rheumatoid arthritis, and Raynaud Syndrome.[ http://pennstatehershey.adam.com/content.aspx?productId=107&pid=33&gid=000301]
Source: Regenstrief LOINC
LP269615-3 Eicosapentaenoate+Docosapentaenate w3+Docosahexaenoate
Docosahexaenoate (DHA) is one of the essential polyunsaturated omega-3 fatty acids that is primarily obtained by ingesting fatty fish including salmon, mackerel, tuna, herring, and sardines.[https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/] There are many benefits derived from eating healthy levels of DHA including a reduction of chronic inflammation, atherosclerosis, hypertension, arthritis, depression, adult-onset diabetes mellitus, myocardial infarction, thrombosis, and some cancers. DHA is important in brain development of infants and in maintaining normal brain function in adults. Studies have demonstrated that infants who drink DHA-fortified formula have higher visual acuity than infants who drink unfortified formula. Deficiencies of DHA have been associated with fetal alcohol syndrome, attention deficit hyperactivity disorder, cystic fibrosis, phenylketonuria, unipolar depression, aggressive hostility, adrenoleukodystrophy, cognitive decline in aging individuals, and the onset of sporadic Alzheimer's disease. Patients who consume 200 mg/day of DHA have a 50% reduction in the incidence of sudden cardiac arrest. PMID: 10479465
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Eicosapentaenoate+Docosapentaenate w3+Docosahexaenoate/Fatty acids.C14-C22
- Property
- MFr
- Time
- Pt
- System
- Bld
- Scale
- Qn
- Method
Additional Names
- Short Name
- EPA+DPA+DHA/Fatty acids.C14-C22 MFr Bld
- Display Name
- EPA+DPA+DHA/Fatty acids.C14-C22 (Bld) [Mass fraction]
- Consumer Name Alpha Get Info
- EPA+DPA+DHA/Fatty Acids.C14-C22, Blood
Basic Attributes
- Class
- CHEM
- Type
- Laboratory
- First Released
- Version 2.65
- Last Updated
- Version 2.65
- Order vs. Observation
- Observation
Member of these Panels
LOINC | Long Common Name |
---|---|
90918-4 | Fatty acid omega-3 and omega-6 panel - Blood |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Eicosapentaenoico + Docosapentaenoico w3 + Docosahexaenoico/Ácidos grasos C14-C22: Synonyms: Cuantitativo |
es-MX | Spanish (Mexico) | Eicosapentaenoato + Docosapentaenato w3 + Docosahexaenoato / Ácidos grasos C14-C22: |
fr-FR | French (France) | Eicosapentaénoate+docosapentaénate w3+Docosahexaénoate/acides gras C14-C22: |
it-IT | Italian (Italy) | Eicosapentaenoato+Docosapentaenate w3+Docosaesaenoato/Acidi grassi.C14-C22: Synonyms: Chimica Docosaesaenoato (C22: |
zh-CN | Chinese (China) | 二十碳五烯酸+二十二碳五烯酸 w3+二十二碳六烯酸/脂肪酸类.C14-C22: Synonyms: C20: |
Example Units
Unit | Source |
---|---|
% | Example UCUM Units |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=90911-9
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright